Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
about
Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
description
scientific article published on 26 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Efficacy and cardiac safety of ...... matic review and meta-analysis
@en
Efficacy and cardiac safety of ...... matic review and meta-analysis
@nl
type
label
Efficacy and cardiac safety of ...... matic review and meta-analysis
@en
Efficacy and cardiac safety of ...... matic review and meta-analysis
@nl
prefLabel
Efficacy and cardiac safety of ...... matic review and meta-analysis
@en
Efficacy and cardiac safety of ...... matic review and meta-analysis
@nl
P2093
P2860
P356
P1476
Efficacy and cardiac safety of ...... matic review and meta-analysis
@en
P2093
Bilal Arshad
Hong-Yuan Li
Jiu-Song Wu
Kai-Nan Wu
Ying-Cun Li
Yu-Tuan Wu
Zhong-Liang Wang
P2860
P304
P356
10.2147/TCRM.S176214
P407
P577
2018-09-26T00:00:00Z